| Literature DB >> 31752192 |
Zhengtao Li1,2.
Abstract
This paper analyzes the choice of illness-cure combinations to estimate people's willingness to pay (WTP) for the reduction of acute health risks correlated with air pollution caused by mining and smelting in the Jinchuan mining area, China. To improve explaining the power of choice experiment (CE), a random parameter logit model (RPL) was employed and extended by considering rank ordered choice sets and non-linear effects of health risk perception on choice behaviors. The results of this study indicated that the ordered RPL approach produced better results than the unordered alternative after comparing different modeling techniques. Perceived health risk, illness attributes, and the residents' external characteristics: income, education, age, family health experience, work environment and proximity to pollution source are important determinants of the Jinchuan people's choice mode for avoiding acute health risks caused by air pollution. Taking all acute illnesses investigated together, the mean Jinchuan household WTP for reducing acute health risk caused by air pollution is 146.69 RMB (abbreviation of Chinese yuan) per year (US$23.38, 0.31% of average yearly household income). On the basis of our findings, we conclude that virtually Jinchuan residents perceive air pollution as a serious health risk. To assist the residents to take appropriate preventive action, the local government should develop counseling and educational campaigns and institutionalize disclosure of air quality conditions.Entities:
Keywords: China; air pollution; model under-specification; perceived health risk; random parameter logit model; willingness to pay
Mesh:
Year: 2019 PMID: 31752192 PMCID: PMC6887755 DOI: 10.3390/ijerph16224563
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Attributes and attribute levels.
| Attribute | Levels of Attributes | Description |
|---|---|---|
| Illness | (1) Acute upper respiratory tract infection | Sneezing, a runny nose, cough and fever |
| (2) Acute Bronchitis | Cough, fever, burning or dull pain in the chest, wheezing. | |
| (3) Acute Pneumonia | Chest pain, fever, and difficulty breathing. | |
| Duration (days) | (1) 5 | 5-day episode |
| (2) 9 | 9-day episode | |
| (3) 15 | 15-day episode | |
| Activity Restriction | (1) No Limitation | No physical limitations nor restrictions of activities |
| (2) At home | Stay in the house, without social or recreational activities | |
| (3) In Hospital | In hospital and help needed to take care of oneself | |
| Price of cure (annual) | (1) 100 RMB | |
| (2) 300 RMB | ||
| (3) 500 RMB |
Based on Johnson et al. [19] and consultation with local doctors.
A typical choice set.
| Alternatives | A | B | C | |
|---|---|---|---|---|
| Attributes | ||||
| Disease | Acute Pneumonia | Acute Bronchitis | I don’t want to purchase either | |
| Duration | 5-day episode | 9-day episode | ||
| Daily activity restriction | At home | At home | ||
| Price of cure (annual) | 300 RMB | 500 RMB | ||
| Which alternative do you prefer to purchase | ||||
Figure 1Heavily, moderately and lightly polluted areas of the Jinchuan mining area. Note: the dominant wind directions are from the east and south-east during summer and from west and north-west during winter. Source: JEQMR [40], Wei [4] and Li et al., [41].
Descriptive statistics for the observed exogenous variables.
| Variables | Min | Max | Mean | S.D. |
|---|---|---|---|---|
|
| 21 | 78 | 44.11 | 11.4 |
|
| 1 | 6 | 3 | 0.78 |
|
| 0 | 1 | 0.33 | 0.48 |
|
| 0 | 7 | 2 | 1.53 |
|
| 1 | 10 | 7.46 | 1.51 |
|
| % |
| % | |
| Primary school | 6.30% | Non-JMC employee (reference case) | 59.55% | |
| Middle school | 23.60% | Miners and smelter workers of JMC (MS) | 18.18% | |
| High school | 25.30% | JMC employee, but not miner or smelter worker (NMS) | 22.27% | |
| Vocational school | 25.30% |
| % | |
| Bachelor’s degree | 19.10% | 1000–2000 | 4.70% | |
| Master’s degree | 0.40% | 2000–3000 | 15.30% | |
| 3000–4000 | 18.30% | |||
|
| % | 4000–5000 | 19.10% | |
| Nearby smelting plants, severe air pollution (SAP) | 29.60% | 5000–6000 | 20.90% | |
| Medium distance, medium air pollution (MAP) | 29.80% | 6000–7000 | 13.00% | |
| Far away from smelting plants, light air pollution (LAP) | 40.60% | More than 7000 | 8.60% | |
Note: Family size: number of family members living in the same house. Family health experience: 1 if the respondent or one or more of their family members have been hospitalized for cardiovascular diseases (e.g., hypertension, heart attack, chest pain, arrhythmia and myocardial infraction) or respiratory diseases (e.g., upper respiratory tract infection, bronchitis, pneumonia, asthma, and lung cancer), 0 otherwise. Source: Author’s survey.
The estimated RPL models.
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
|---|---|---|---|---|---|---|
| Ordered-RPL Model with | Ordered-RPL Model without | Unordered-RPL Model with | ||||
| Variables | Coefficient | T-Value | Coefficient | T-Value | Coefficient | T-Value |
| Acute upper respiratory tract infection * ln(duration + 1) (AI*LD) | 0.106 | - | 0.101 | - | −0.047 | - |
| S.D. | - | - | - | - | - | - |
| Acute Bronchitis * ln(Duration + 1) (AB*LD) | −0.057 ** | −2.067 | −0.061 ** | −2.205 | −0.038 | −1.381 |
| S.D. | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
| Acute Pneumonia * ln(Duration + 1) (AP*LD) | −0.049 * | −1.722 | −0.050 * | −1.757 | 0.009 | 0.354 |
| S.D. | 0.489 *** | 13.788 | 0.481 *** | 13.508 | 0.445 *** | 12.720 |
| No Limitation (NL) | 0.661 | - | 0.715 | - | 0.698 | - |
| S.D. | - | - | - | - | - | - |
| At home (AH) | −0.040 | −0.069 | −0.040 | −0.073 | 0.087 | 0.151 |
| S.D. | 0.000 | 0.000 | 0.000 | 0.000 | −0.002 | 0.000 |
| In hospital (IH) | −0.621 *** | −5.874 | −0.675 *** | −6.098 | −0.611 *** | −5.605 |
| S.D. | 1.545 *** | 8.618 | 1.607 *** | 8.889 | 1.622 *** | 9.551 |
|
| 0.037 *** | 5.383 | 0.037 *** | 5.490 | 0.007 ** | 2.130 |
|
| 0.226 *** | 4.934 | 0.218 *** | 4.623 | ||
|
| 0.175 **** | 4.238 | 0.190 *** | 4.520 | ||
|
| −0.147 *** | −9.583 | −0.148 *** | −9.289 | ||
|
| −0.085 *** | −6.079 | −0.125 *** | −8.857 | ||
|
| −0.134 **** | −3.623 | −0.108 *** | −2.865 | ||
|
| −0.086 *** | −2.580 | −0.091 *** | −2.726 | ||
|
| −0.044 *** | −3.178 | −0.030 ** | −2.144 | ||
|
| −0.017 | −1.327 | −0.024 * | −1.853 | ||
|
| 0.139 *** | 6.251 | 0.087 *** | 3.961 | ||
|
| 0.086 *** | 4.406 | 0.046 ** | 2.465 | ||
|
| 0.161 | 1.503 | 0.117 | 1.096 | 0.308 *** | 2.882 |
|
| 0.563 *** | 5.613 | 0.533 *** | 5.352 | 0.434 *** | 4.438 |
|
| −0.342 *** | −5.039 | −0.296 *** | −4.346 | −0.357 *** | −5.200 |
|
| −0.294 *** | −4.583 | −0.256 *** | −4.016 | −0.333 *** | −5.340 |
|
| −0.056 | −1.123 | −0.077 | −1.553 | −0.012 | −0.243 |
|
| 0.097 ** | 2.152 | 0.082 * | 1.842 | 0.030 | 0.682 |
|
| 0.259 *** | 7.207 | 0.243 *** | 6.968 | 0.305 *** | 8.605 |
|
| 0.396 *** | 11.557 | 0.386 *** | 11.522 | 0.355 *** | 10.706 |
|
| −0.267 *** | −5.341 | −0.250 *** | −5.182 | −0.315 *** | −6.345 |
|
| −0.352 *** | −7.654 | −0.338 *** | −7.610 | −0.333 *** | −7.363 |
|
| 0.309 *** | 2.032 | 0.221 | 1.512 | 0.291 * | 1.921 |
|
| 0.275 ** | 1.993 | 0.221 * | 1.657 | 0.236 * | 1.709 |
|
| −0.031 | −0.237 | −0.010 | −0.078 | −0.153 | −1.170 |
|
| −0.441 *** | −3.491 | −0.422 *** | −3.342 | −0.304 ** | −2.504 |
|
| −0.081 | −0.713 | −0.036 | −0.325 | 0.072 | 0.647 |
|
| 0.278 *** | 2.630 | 0.328 *** | 3.208 | 0.184 * | 1.797 |
|
| 759 | 759 | 759 | |||
| Log-likelihood | −4139 | −4195.7 | −4206.7 | |||
| McFadden R square | 0.106 | 0.094 | 0.091 | |||
Note: One, two, three and four stars (*) indicate respectively significance at the 10%, 5%, 1% and 0.5% level. Variable subscripts in ordered-RPL model denote choice mode: A = alternative A: relatively mild illness with low prevention price; B = alternative B: relatively sever illness with high prevention price.
Heterogeneous effects of perceived health risk on choice behavior, by proximity to pollution source.
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
|---|---|---|---|---|---|---|
| Variables | Lightly Polluted Areas | T-Value | Moderate Polluted Areas | T-Value | Severely Polluted Areas | T-Value |
| Acute upper respiratory tract infection * ln(duration + 1) (AI*LD) | 0.091 | - | 0.175 | - | 0.087 | - |
| Acute Bronchitis * ln(Duration + 1) (AB*LD) | −0.051 | −1.4435 | −0.069 | −1.0497 | −0.055 | −0.8611 |
| SD | 0.000 | 0.0000 | 0.001 | 0.0002 | 0.000 | 0.0001 |
| Acute Pneumonia * ln(Duration + 1) (AP*LD) | −0.040 | −1.0864 | −0.106 | −1.5615 | −0.032 | −0.4920 |
| S.D | 0.478 ** | 10.7158 | 0.589 *** | 6.6072 | 0.462 *** | 5.9455 |
| No Limitation (NL) | 0.582 | - | 0.683 | - | 0.918 | - |
| At home (AH) | −0.007 | −0.0091 | −0.087 | −0.0639 | −0.073 | −0.0578 |
| S.D | 0.000 | 0.0001 | 0.003 | 0.0004 | 0.007 | 0.0009 |
| In hospital (IH) | −0.575 *** | −4.3801 | −0.596 *** | −2.7580 | −0.845 *** | −3.0156 |
| S.D | 1.441 *** | 6.1734 | 1.667 *** | 4.2456 | 2.051 *** | 5.2880 |
|
| 0.033 *** | 3.8242 | 0.046 *** | 2.5976 | 0.034 ** | 2.1298 |
|
| 0.338 *** | 5.3933 | 0.472 *** | 3.5962 | −0.138 | −0.9936 |
|
| 0.188 *** | 3.5165 | 0.492 *** | 4.6626 | −0.072 | −0.5175 |
|
| −0.174 *** | −7.5286 | −0.208 *** | −5.4870 | −0.028 | −0.3514 |
|
| −0.068 *** | −3.4167 | −0.185 *** | −5.7982 | 0.046 | 0.5995 |
|
| −0.208 *** | −4.2627 | −0.245 * | 1.6711 | 0.150 | 1.2373 |
|
| −0.065 | −1.5533 | −0.332 ** | −2.4187 | 0.108 | 0.9257 |
|
| −0.065 *** | −4.0336 | −0.050 | −0.6199 | 0.077 | 1.0756 |
|
| −0.013 | −0.9055 | −0.051 | −0.6646 | 0.051 | 0.7804 |
|
| 0.230 *** | 6.1769 | 0.103 | 1.6321 | −0.163 | −1.5038 |
|
| 0.138 *** | 4.6727 | −0.007 | −0.1060 | −0.136 | −1.2492 |
|
| −0.079 | −0.5857 | −0.616 * | −1.7600 | 1.745 *** | 5.0478 |
|
| 0.268 ** | 2.1420 | −0.275 | −0.8729 | 2.626 *** | 7.5509 |
|
| −0.312 *** | −3.8581 | 0.151 | 0.5283 | −0.902 *** | −3.4883 |
|
| −0.242 *** | −3.2633 | 0.148 | 0.5275 | −0.887 *** | −3.1262 |
|
| 0.002 | 0.0319 | −0.352 ** | −2.1124 | −0.314 ** | −2.2428 |
|
| 0.151 ** | 2.6563 | −0.242 * | −1.6921 | −0.153 | −1.1751 |
|
| 0.269 *** | 6.0633 | 0.395 *** | 3.5805 | 0.349 *** | 3.4411 |
|
| 0.392 *** | 9.3348 | 0.422 *** | 4.0159 | 0.836 *** | 8.1224 |
|
| −0.264 *** | −4.4248 | −0.396 *** | −2.6258 | −0.083 | −0.4215 |
|
| −0.310 *** | −5.6574 | −0.434 *** | −2.9395 | −0.353 ** | −2.0753 |
|
| −0.20321 | −1.3685 | −1.357 *** | −3.4844 | 1.415 *** | 5.0928 |
|
| 0.230096 * | 1.6857 | −1.083 *** | −2.9658 | 2.034 *** | 7.1594 |
|
| 220 | 221 | 318 | |||
| Log-likelihood | −2488.4 | −773.87 | −743.78 | |||
| McFadden R square | 0.110 | 0.140 | 0.184 |
Note: One, two and three stars (*) indicate respectively significance at the 10%, 5%, and 1% level.
Average WTP estimates by disease, activity restriction and duration (RMB per year).
| 1 | 2 | 3 | 4 | 5 |
|---|---|---|---|---|
| Disease | Duration | Activity Restriction Level | ||
| No Limitation | At Home | In Hospital | ||
| Acute upper respiratory tract infection (AI) | 5 | 0 | 0 | - |
| 9 | 0 | 0 | - | |
| 15 | 0 | 0 | - | |
| Acute bronchitis (AB) | 5 | 0 | 3.833 | 19.551 |
| 9 | 0 | 4.619 | 20.337 | |
| 15 | 0 | 5.342 | 21.060 | |
| Acute pneumonia (AP) | 5 | 0 | 3.468 | 19.186 |
| 9 | 0 | 4.150 | 19.868 | |
| 15 | 0 | 4.778 | 20.495 | |
Choice set 1.
| Alternative | A | B | C |
|---|---|---|---|
| Disease | Acute Pneumonia | Acute Pneumonia | I don’t want to purchase either |
| Duration | 9-day episode | 15-day episode | |
| Daily activity | No Limitation | No Limitation | |
| Price | 300 RMB | 500 RMB | |
| Which alternative do you prefer to purchase |
Choice set 2.
| Alternative | A | B | C |
|---|---|---|---|
| Disease | Acute Bronchitis | Acute Bronchitis | I don’t want to purchase either |
| Duration | 5-day episode | 5-day episode | |
| Daily activity | At home | In Hospital | |
| Price | 300 RMB | 500 RMB | |
| Which alternative do you prefer to purchase |
Choice set 3.
| Alternative | A | B | C |
|---|---|---|---|
| Disease | Acute upper respiratory tract infection | Acute Pneumonia | I don’t want to purchase either |
| Duration | 9-day episode | 5-day episode | |
| Daily activity | At home | No Limitation | |
| Price | 300 RMB | 100 RMB | |
| Which alternative do you prefer to purchase |
Choice set 4.
| Alternative | A | B | C |
|---|---|---|---|
| Disease | Acute upper respiratory tract infection | Acute Bronchitis | I don’t want to purchase either |
| Duration | 5-day episode | 15-day episode | |
| Daily activity | At home | In Hospital | |
| Price | 300 RMB | 500 RMB | |
| Which alternative do you prefer to purchase |
Choice set 5.
| Alternative | A | B | C |
|---|---|---|---|
| Disease | Acute Pneumonia | Acute Bronchitis | I don’t want to purchase either |
| Duration | 9-day episode | 15-day episode | |
| Daily activity | No Limitation | No Limitation | |
| Price | 100 RMB | 300 RMB | |
| Which alternative do you prefer to purchase |
Choice set 6.
| Alternative | A | B | C |
|---|---|---|---|
| Disease | Acute Bronchitis | Acute Pneumonia | I don’t want to purchase either |
| Duration | 9-day episode | 5-day episode | |
| Daily activity | At home | At home | |
| Price | 500 RMB | 300 RMB | |
| Which alternative do you prefer to purchase |
Choice set 1.
| Alternative | A | B | C |
|---|---|---|---|
| Disease | Acute Pneumonia | Acute Pneumonia | I don’t want to purchase either |
| Duration | 9-day episode | 15-day episode | |
| Daily activity | No Limitation | No Limitation | |
| Price | 300 RMB | 500 RMB | |
| Which alternative do you prefer to purchase |
Choice set 2.
| Alternative | A | B | C |
|---|---|---|---|
| Disease | Acute Bronchitis | Acute Bronchitis | I don’t want to purchase either |
| Duration | 5-day episode | 5-day episode | |
| Daily activity | At home | In Hospital | |
| Price | 300 RMB | 500 RMB | |
| Which alternative do you prefer to purchase |
Choice set 3.
| Alternative | A | B | C |
|---|---|---|---|
| Disease | Acute Pneumonia | Acute upper respiratory tract infection | I don’t want to purchase either |
| Duration | 5-day episode | 9-day episode | |
| Daily activity | No Limitation | At home | |
| Price | 100 RMB | 300 RMB | |
| Which alternative do you prefer to purchase |
Choice set 4.
| Alternative | A | B | C |
|---|---|---|---|
| Disease | Acute upper respiratory tract infection | Acute Bronchitis | I don’t want to purchase either |
| Duration | 5-day episode | 15-day episode | |
| Daily activity | At home | In Hospital | |
| Price | 300 RMB | 500 RMB | |
| Which alternative do you prefer to purchase |
Choice set 5.
| Alternative | A | B | C |
|---|---|---|---|
| Disease | Acute Pneumonia | Acute Bronchitis | I don’t want to purchase either |
| Duration | 9-day episode | 15-day episode | |
| Daily activity | No Limitation | No Limitation | |
| Price | 100 RMB | 300 RMB | |
| Which alternative do you prefer to purchase |
Choice set 6.
| Alternative | A | B | C |
|---|---|---|---|
| Disease | Acute Pneumonia | Acute Bronchitis | I don’t want to purchase either |
| Duration | 5-day episode | 9-day episode | |
| Daily activity | At home | At home | |
| Price | 300 RMB | 500 RMB | |
| Which alternative do you prefer to purchase |